Skip to main content

NL INDUSTRIES INC

For the period ended Mar 31, 2026. Filed May 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

NL$7.32+2.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to Condensed Consolidated Financial Statements (unaudited)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(unaudited)

Note 1 – Organization and basis of presentation:

Organization– At March 31, 2026, Valhi, Inc. (NYSE: VHI) held approximately 83% of our outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 91% of Valhi’s outstanding common stock. A majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons and by family stockholders (Thomas C. Connelly (the husband of Ms. Simmons’ late sister), a family-owned entity and various family trusts established for the benefit of Ms. Simmons, Mr. Connelly and their children) who are required to vote their shares of Contran voting stock in the same manner as Ms. Simmons. Such voting rights are personal to Ms. Simmons and last through April 22, 2030. The remainder of Contran’s outstanding voting stock is held by another trust (the “Family Trust”), which was established for the benefit of Ms. Simmons and her late sister and their children and for which a third-party financial institution serves as trustee. Consequently, at March 31, 2026, Ms. Simmons and the Family Trust may be deemed to control Contran, and therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi and us.

Basis of presentation– Consolidated in this Quarterly Report are the results of our majority-owned subsidiary, CompX International Inc. We also own approximately 31% of Kronos Worldwide, Inc. (“Kronos”). CompX (NYSE American: CIX) and Kronos (NYSE: KRO) each file periodic reports with the Securities and Exchange Commission (“SEC”).

The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025 that we filed with the SEC on March 9, 2026 (the “2025 Annual Report”). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2025 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2025) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Our results of operations for the interim period ended March 31, 2026 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2025 Consolidated Financial Statements contained in our 2025 Annual Report.

Unless otherwise indicated, references in this report to “NL,” “we,” “us” or “our” refer to NL Industries, Inc. and its subsidiaries and affiliate, Kronos, taken as a whole.

Note 2 – Segment information:

Our chief operating decision maker (“CODM”) evaluates segment performance based on net income and segment profit (a non-GAAP measure), which we define as gross margin less selling, general and administrative expenses directly attributable to CompX. Differences between segment profit and the amounts included in net income (loss) are included in the table below. Substantially alldepreciation and amortization amounts are included in the calculation of segment profit.

​​​​​​​
​ · ​ · Three months ended March 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2026
​ · ​ · (In thousands)
Net sales​$40,272​$40,569
​​​​​​​
Segment profit​​5,869​​7,050
Corporate expenses​​(2,721)​​(2,943)
Equity in earnings (losses) of Kronos Worldwide, Inc.​​5,525​​(1,477)
Interest and dividend income​​2,038​​1,252
Marketable equity securities​​(8,552)​​2,695
Other components of net periodic pension and OPEB cost​​(285)​​—
Interest expense​​(575)​​(11)
Income tax benefit (expense)​​23​​(1,472)
Net income​$1,322​$5,094

Note 3 – Accounts and other receivables, net:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​March 31,
​​ ​ ​2025​ ​ ​2026
​ · ​ · (In thousands)
Trade receivables - CompX​$13,836​$19,029
Other receivables​35​30
Allowance for doubtful accounts​(70)​(70)
Total​$13,801​$18,989

Note 4 – Inventories, net:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​March 31,
​​ ​ ​2025​ ​ ​2026
​ · ​ · (In thousands)
Raw materials​$5,620​$5,343
Work in process​19,907​20,324
Finished products​4,883​4,403
Total​$30,410​$30,070

Note 5 – Marketable securities:

Our noncurrent marketable securities are equity securities and consist of our investment in the publicly-traded shares of our immediate parent company Valhi, Inc. Our shares of Valhi common stock are accounted for as available-for-sale securities, which are carried at fair value using quoted market prices in active markets and represent a Level 1 input within the fair value hierarchy, as defined by ASC Topic 820,Fair Value Measurements and Disclosures. We record any unrealized gains or losses on the securities in other income (expense) on our Condensed Consolidated Statements of Operations.

​​​​​​​​​​​​
​ · ​ · Fair value · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · measurement · ​ · Market · ​ · Cost · ​ · Unrealized
​ · ​ ​ ​ · level · ​ ​ ​ · value · ​ ​ ​ · basis · ​ ​ ​ · loss, net
​ · ​ · ​ · ​ · (In thousands)
December 31, 2025​​​​​​​​​​​
Noncurrent assets - Valhi common stock1​$14,433​$24,347​$(9,914)
​​​​​​​​​​​​
March 31, 2026​​​​​​​​​​​
Noncurrent assets - Valhi common stock​1​$17,128​$24,347​$(7,219)

At December 31, 2025 and March 31, 2026, we held approximately 1.2 million shares of common stock our immediate parent company, Valhi, Inc. At December 31, 2025 and March 31, 2026, the quoted per share market price of Valhi common stock was $12.05 and $14.30, respectively.

The Valhi common stock we own is subject to restrictions on resale pursuant to certain provisions of the SEC Rule 144. In addition, as a majority-owned subsidiary of Valhi we cannot vote our shares of Valhi common stock under Delaware General Corporation Law, but we do receive dividends from Valhi on these shares, when declared and paid.

Note 6 – Investment in Kronos Worldwide, Inc.:

At December 31, 2025 and March 31, 2026, we owned approximately 35.2 million shares of Kronos common stock. At March 31, 2026, the quoted market price of Kronos’ common stock was $6.57 per share, or an aggregate market value of $231.4 million. At December 31, 2025, the quoted market price was $4.42 per share, or an aggregate market value of $155.7 million.

The change in the carrying value of our investment in Kronos during the first three months of 2026 is summarized below.

​​​​
​ · ​ ​ ​ · Amount
​ · ​ · (In millions)
Balance at the beginning of the period​$230.1
Equity in losses of Kronos​(1.5)
Dividends received from Kronos​(1.8)
Equity in Kronos' other comprehensive income:​​​
Currency translation​​1.3
Defined benefit pension plans​​.1
Balance at the end of the period​$228.2

Selected financial information of Kronos is summarized below:

​​​​​​​
​ · ​ · December 31, · ​ · March 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2026
​ · ​ · (In millions)
Current assets​$994.5​$988.5
Property and equipment, net​724.3​712.6
Other noncurrent assets​98.0​97.2
Total assets​$1,816.8​$1,798.3
​​​​​​​
Current liabilities​$368.8​$311.0
Long-term debt​557.4​602.7
Accrued pension costs​80.9​76.4
Other noncurrent liabilities​58.6​63.2
Stockholders’ equity​751.1​745.0
Total liabilities and stockholders’ equity​$1,816.8​$1,798.3
​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Three months ended
​ · ​ · March 31,
​​ ​ ​2025​ ​ ​2026
​ · ​ · (In millions)
Net sales​$489.8​$509.8
Cost of sales​383.0​426.5
Income from operations​38.4​12.6
Income tax expense​7.6​2.8
Net income (loss)​18.1​(4.8)

Note 7– Accrued and other current liabilities:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​March 31,
​​ ​ ​2025​ ​ ​2026
​ · ​ · (In thousands)
Employee benefits​$11,569​$5,896
Other​3,452​2,276
Total​$15,021​$8,172

Note 8 – Long-term debt:

During the first three months of 2026, our wholly-owned subsidiary, NLKW Holding, LLC hadno borrowings or repayments under its $50 million secured revolving credit facility with Valhi. At March 31, 2026, $.5 million was outstanding and $49.5 million was available for future borrowing under this facility. Outstanding borrowings bear interest at theprime rate plus 1.875% per annum, and the average interest rate as of and for the three months ended March 31, 2026 was 8.6%. We are in compliance with all covenants at March 31, 2026.

Note 9 – Leases:

In March 2026, CompX entered into an operating lease for its distribution center located in Southern California. Upon commencement, we recognized an operating lease right-of-use asset and a corresponding operating lease liability, which are included in our Condensed Consolidated Balance Sheet. As of March 31, 2026, the remaining lease term of CompX’s operating lease was approximately 7 years and the discount rate associated with such lease was 6.75%.

Note 10 – Other noncurrent liabilities:

​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · December 31, · ​ · March 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2026
​ · ​ · (In thousands)
OPEB​$312​$261
Insurance claims and expenses​​684​746
Other​​281​192
Total​$1,277​$1,199

Note 11 – Revenue recognition:

The following table disaggregates our net sales by reporting unit, which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Three months ended
​ · ​ · March 31,
​​ ​ ​2025​ ​ ​2026
​ · ​ · (In thousands)
Net sales: · ​ · ​ · ​ · ​ · ​ · ​
Security Products​$30,230​$29,896
Marine Components​10,042​10,673
Total​$40,272​$40,569

Note 12 – Income taxes:

​​​​​​​
​ · ​ · Three months ended
​ · ​ · March 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2026
​ · ​ · (In thousands)
Expected tax expense, at U.S. federal statutory income tax rate of 21%​$273​$1,379
Rate differences on equity in earnings (losses) of Kronos, net of dividends​(319)​(25)
U.S. state income taxes and other, net​23​118
Income tax expense (benefit)​$(23)​$1,472
​​​​​​​
Comprehensive provision for income taxes allocable to:​​​​
Net income​$(23)​$1,472
Other comprehensive income (loss):​​​​
Currency translation​1,112​270
Defined benefit pension plans​85​23
Other​(9)​—
Comprehensive income tax expense​$1,165​$1,765

In accordance with GAAP, we recognize deferred income taxes on our undistributed equity in earnings of Kronos. Because we and Kronos are part of the same U.S. federal income tax group, any dividends we receive from Kronos are nontaxable to us. Accordingly, we do not recognize and we are not required to pay income taxes on dividends from Kronos. We received aggregate dividends from Kronos of $1.8 million in each of the first three months of 2025 and 2026, respectively. The amounts shown in the above table of our income tax rate reconciliation for rate differences on equity in earnings (losses) of Kronos, net of dividends, represent the income tax benefit associated with the nontaxable dividends we received from Kronos compared to the amount of deferred income taxes we recognized on our equity in earnings (losses) of Kronos.

On July 4, 2025, the One Big Beautiful Bill Act was signed into law in the United States. It did not have a material impact on our consolidated financial statements.

Note 13 –** **Stockholders’ equity:

*Accumulated other comprehensive loss -*Changes in accumulated other comprehensive loss attributable to NL stockholders, including amounts resulting from our investment in Kronos Worldwide (see Note 6), are presented in the table below.

​​​​​​​
​ · ​ · Three months ended
​ · ​ · March 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2026
​​(In thousands)
Accumulated other comprehensive loss, (net of tax and noncontrolling interest):​​​​​​
Currency translation:​​​​​​
Balance at beginning of period​$(185,423)​$(177,512)
Other comprehensive income​4,185​1,015
Balance at end of period​$(181,238)​$(176,497)
​​​​​​​
Defined benefit pension plans:​​​​​​
Balance at beginning of period​$(36,666)​$(17,359)
Other comprehensive income -​​​​​​
Amortization of prior service cost and net losses included in net periodic pension cost​317​86
Balance at end of period​$(36,349)​$(17,273)
​​​​​​​
OPEB plans:​​​​​​
Balance at beginning of period​$(1,267)​$(1,196)
Other comprehensive loss -​​​​​​
Amortization of net gain included in net periodic OPEB cost​(33)​1
Balance at end of period​$(1,300)​$(1,195)
​​​​​​​
Total accumulated other comprehensive loss:​​​​​​
Balance at beginning of period​$(223,356)​$(196,067)
Other comprehensive income​​4,469​​1,102
Balance at end of period​$(218,887)​$(194,965)

Note 14 – Commitments and contingencies:

General

We are involved in various environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our current and former businesses. At least quarterly our management discusses and evaluates the status of any pending litigation or claim to which we are a party or which has been asserted against us. The factors considered in such evaluation include, among other things, the nature of such pending cases and claims, the status of such pending cases and claims, the advice of legal counsel and our experience in similar cases and claims (if any). Based on such evaluation, we make a determination as to whether we believe (i) it is probable a loss has been incurred, and if so, if the amount of such loss (or a range of loss) is reasonably estimable, or (ii) it is reasonably possible but not probable a loss has been incurred, and if so, if the amount of such loss (or a range of loss) is reasonably estimable, or (iii) the probability a loss has been incurred is remote.

Lead pigment litigation

Our former operations included the manufacture of lead pigments for use in paint and lead-based paint. We, other former manufacturers of lead pigments for use in paint and lead-based paint (together, the “former pigment manufacturers”), and the Lead Industries Association (“LIA”), which discontinued business operations in 2002, have previously been named as defendants in various legal proceedings seeking damages for personal injury, property damage and governmental expenditures allegedly caused by the use of lead-based paints. Certain of these actions were filed by or on behalf of states, counties, cities or their public housing authorities and school districts, and certain others were asserted as class actions. We currently have no pending lead paint class action cases or pending lead paint cases brought by housing authorities, school districts or other government entities.

New cases may continue to be filed against us. We do not know if we will incur liability in the future in respect of any of the pending or possible litigation in view of the inherent uncertainties involved in court and jury rulings. In the future, if new information regarding such matters becomes available to us (such as a final, non-appealable adverse verdict against us or otherwise ultimately being found liable with respect to such matters), at that time we would consider such information in evaluating any remaining cases then-pending against us as to whether it might then have become probable we have incurred liability with respect to these matters, and whether such liability, if any, could have become reasonably estimable. The resolution of any of these cases could result in the recognition of a loss contingency accrual that could have a material adverse impact on our net income for the interim or annual period during which such liability is recognized and a material adverse impact on our consolidated financial condition and liquidity.

Environmental matters and litigation

Our operations are governed by various environmental laws and regulations. Certain of our businesses are and have been engaged in the handling, manufacture or use of substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged in similar businesses, certain of our past and current operations and products have the potential to cause environmental or other damage. We have implemented and continue to implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations at all of our plants and to strive to improve environmental performance. From time to time, we may be subject to environmental regulatory enforcement under U.S. statutes, the resolution of which typically involves the establishment of compliance programs. It is possible that future developments, such as stricter requirements of environmental laws and enforcement policies, could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We believe all of our facilities are in substantial compliance with applicable environmental laws.

Certain properties and facilities used in our former operations, including divested primary and secondary lead smelters and former mining locations, are the subject of civil litigation, administrative proceedings or investigations arising under federal and state environmental laws and common law. Additionally, in connection with past operating practices, we are currently involved as a defendant, potentially responsible party (“PRP”) or both, pursuant to the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund Amendments and Reauthorization Act (“CERCLA”), and similar state laws in various governmental and private actions associated with waste disposal sites, mining locations, and facilities that we or our predecessors, our subsidiaries or their predecessors currently or previously owned, operated or used, certain of which are on the United States Environmental Protection Agency’s (“EPA”) Superfund National Priorities List or similar state lists. These proceedings seek cleanup costs, damages for personal injury or property damage and/or damages for injury to natural resources. Certain of these proceedings involve claims for substantial amounts. Although we may be jointly and severally liable for these costs, in most cases we are only one of a number of PRPs who may also be jointly and severally liable, and among whom costs may be shared or allocated. In addition, we are occasionally named as a party in a number of personal injury lawsuits filed in various jurisdictions alleging claims related to environmental conditions alleged to have resulted from our operations.

Obligations associated with environmental remediation and related matters are difficult to assess and estimate for numerous reasons including the:

●complexity and differing interpretations of governmental regulations,
●number of PRPs and their ability or willingness to fund such allocation of costs,
●financial capabilities of the PRPs and the allocation of costs among them,
●solvency of other PRPs,
●multiplicity of possible solutions,
●number of years of investigatory, remedial and monitoring activity required,
●uncertainty over the extent, if any, to which our former operations might have contributed to the conditions allegedly giving rise to such personal injury, property damage, natural resource and related claims, and
●number of years between former operations and notice of claims and lack of information and documents about the former operations.

In addition, the imposition of more stringent standards or requirements under environmental laws or regulations, new developments or changes regarding site cleanup costs or the allocation of costs among PRPs, solvency of other PRPs, the results of future testing and analysis undertaken with respect to certain sites or a determination that we are potentially responsible for the release of hazardous substances at other sites, could cause our expenditures to exceed our current estimates. Actual costs could exceed accrued

amounts or the upper end of the range for sites for which estimates have been made, and costs may be incurred for sites where no estimates presently can be made. Further, additional environmental and related matters may arise in the future. If we were to incur any future liability, this could have a material adverse effect on our Condensed Consolidated Financial Statements, results of operations and liquidity.

We record liabilities related to environmental remediation and related matters (including costs associated with damages for personal injury or property damage and/or damages for injury to natural resources) when estimated future expenditures are probable and reasonably estimable. We adjust such accruals as further information becomes available to us or as circumstances change. Unless the amounts and timing of such estimated future expenditures are fixed and reasonably determinable, we generally do not discount estimated future expenditures to their present value due to the uncertainty of the timing of the payout. We recognize recoveries of costs from other parties, if any, as assets when their receipt is deemed probable.

We do not know and cannot estimate the exact time frame over which we will make payments for our accrued environmental and related costs. The timing of payments depends upon a number of factors, including but not limited to the timing of the actual remediation process; which in turn depends on factors outside of our control. At each balance sheet date, we estimate the amount of our accrued environmental and related costs which we expect to pay within the next twelve months, and we classify this estimate as a current liability. We classify the remaining accrued environmental costs as a noncurrent liability.

Changes in the accrued environmental remediation and related costs during the first three months of 2026 are as follows:

​​​​
​ · ​ · Amount
​ · ​ ​ ​ · (In thousands)
​​​​
Balance at the beginning of the period​$13,040
Additions charged to expense, net​378
Payments, net​(449)
Balance at the end of the period​$12,969
​​​​
Amounts recognized in the Condensed Consolidated Balance Sheet at the end of the period:​​​
Current liability​$2,096
Noncurrent liability​​10,873
Balance at the end of the period​$12,969

On a quarterly basis, we evaluate the potential range of our liability for environmental remediation and related costs at sites where we have been named as a PRP or defendant, including sites for which our wholly-owned environmental management subsidiary, NL Environmental Management Services, Inc. (“EMS”), has contractually assumed our obligations. At March 31, 2026, we had accrued approximately $13 million related to approximately 27 sites associated with remediation and related matters we believe are at the present time and/or in their current phase reasonably estimable. The upper end of the range of reasonably possible costs to us for remediation and related matters for which we believe it is possible to estimate costs is approximately $38 million, including the amounts currently accrued. These accruals have not been discounted to present value.

We believe it is not reasonably possible to estimate the range of costs for certain sites. At March 31, 2026, there were approximately five sites for which we are not currently able to reasonably estimate a range of costs. For these sites, generally the investigation is in the early stages, and we are unable to determine whether or not we actually had any association with the site, the nature of our responsibility, if any, for the contamination at the site, if any, and the extent of contamination at and cost to remediate the site. The timing and availability of information on these sites is dependent on events outside of our control, such as when the party alleging liability provides information to us. At certain of these previously inactive sites, we have received general and special notices of liability from the EPA and/or state agencies alleging that we, sometimes with other PRPs, are liable for past and future costs of remediating environmental contamination allegedly caused by former operations. These notifications may assert that we, along with any other alleged PRPs, are liable for past and/or future clean-up costs. As further information becomes available to us for any of these sites, which would allow us to estimate a range of costs, we would at that time adjust our accruals. Any such adjustment could result in the recognition of an accrual that would have a material effect on our Consolidated Financial Statements, results of operations and liquidity.

Insurance coverage claims

We are involved in certain legal proceedings with a number of our former insurance carriers regarding the nature and extent of the carriers’ obligations to us under insurance policies with respect to certain lead pigment and asbestos lawsuits. The issue of whether

insurance coverage for defense costs or indemnity or both will be found to exist for our lead pigment and asbestos litigation depends upon a variety of factors and we cannot assure you that such insurance coverage will be available.

We have agreements with certain of our former insurance carriers pursuant to which the carriers reimburse us for a portion of our future lead pigment litigation defense costs, and one such carrier reimburses us for a portion of our future asbestos litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by us because of certain issues that arise regarding which defense costs qualify for reimbursement. While we continue to seek additional insurance recoveries, we do not know if we will be successful in obtaining reimbursement for either defense costs or indemnity. Accordingly, we recognize insurance recoveries in income only when receipt of the recovery is probable and we are able to reasonably estimate the amount of the recovery.

For a complete discussion of certain litigation involving us and certain of our former insurance carriers, refer to our 2025 Annual Report.

Other litigation

In addition to the litigation described above, we and our affiliates are also involved in various other environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to present and former businesses. In certain cases, we have insurance coverage for these items, although we do not expect additional material insurance coverage for environmental matters. We currently believe the disposition of all of these various other claims and disputes (including asbestos-related claims), individually and in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals already provided.

Note 15 – Financial instruments:

See Note 5 for information on how we determine fair value of our marketable securities.

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · December 31, 2025 · ​ · March 31, 2026
​​Carrying​Fair​Carrying​Fair
​​ ​ ​amount​ ​ ​value​ ​ ​amount​ ​ ​value
​ · ​ · (In thousands)
Cash, cash equivalents and restricted cash​$114,053​$114,053​$105,351​$105,351

Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value.

Note 16 –Recent Accounting Pronouncements:

In November 2024, the FASB issued ASU No. 2024-03,Reporting Comprehensive Income - Expense Disaggregation Disclosures. The ASU requires additional information about specific expense categories in the notes to financial statements for both interim and annual reporting periods. The ASU is effective for us beginning with our 2027 Annual Report, and for interim reporting, in the first quarter of 2028, with early adoption permitted. We are in the process of evaluating the additional disclosure requirements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.